Clinical Cancer Research CR Surrogrates Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyake, Y.
Right arrow Articles by Monden, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyake, Y.
Right arrow Articles by Monden, M.
Clinical Cancer Research Vol. 7, 1350-1357, May 2001
© 2001 American Association for Cancer Research


Molecular Oncology

Extensive Micrometastases to Lymph Nodes as a Marker for Rapid Recurrence of Colorectal Cancer

A Study of Lymphatic Mapping1

Yasuhiro Miyake, Hirofumi Yamamoto2, Yoshiyuki Fujiwara, Masayuki Ohue, Yurika Sugita, Naohiro Tomita, Mitsugu Sekimoto, Nariaki Matsuura, Hitoshi Shiozaki and Morito Monden

Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka 565-0871 [Y. M., H. Y., Y. F., M. O., Y. S., M. S., H. S., M. M.]; Department of Surgery, Kansai Rosai Hospital, Hyogo 660-0064, [N. T.]; and Department of Pathology, School of Allied Health Science, Faculty of Medicine, Osaka University, Osaka 565-0871 [N. M.], Japan

To provide a detailed assessment of micrometastases of colorectal cancer by anatomical mapping of regional lymph nodes (LNs), we analyzed 237 LNs from 11 patients with colorectal cancer by reverse transcription-PCR (RT-PCR) using carcinoembryonic antigen and cytokeratin 20 as genetic markers. All dissected LNs were mapped anatomically and subjected to detection assays for micrometastases. Immunohistochemical analysis was also performed using anti-pancytokeratin antibody AE1/AE3 to confirm the existence of occult cancer cells. By histological analysis, 20 of 237 LNs contained metastatic cells, and they were all positive by both immunohistochemistry and RT-PCR. Of the 217 histologically negative LNs, 14 (6.5%) harbored micrometastases by immunohistochemistry, and 57 (26.2%) were positive for at least one of the two genetic markers. Lymphatic mappings of all patients showed that micrometastases were distributed not only at the pericolic LNs but often at distant LNs. Clinical follow-up study showed that two patients developed recurrence within 1 year after surgery, and both of them had RT-PCR-positive micrometastases in not less than 70% of LNs examined. Moreover, both patients had frequent micrometastases at distant LNs, i.e., those around the root or along the inferior mesenteric artery, when compared with patients with no recurrence. Our findings suggest that genetic diagnosis using the RT-PCR method may be clinically useful along with conventional pathological diagnosis, especially when micrometastases spread to distant LNs.




This article has been cited by other articles:


Home page
Ann OncolHome page
S. Benlloch, J. M. Galbis-Caravajal, C. Alenda, F. M. Peiro, M. Sanchez-Ronco, J. M. Rodriguez-Paniagua, B. Baschwitz, E. Rojas, and B. Massuti
Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases
Ann. Onc., January 1, 2009; 20(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. L. Greene, A. K. Stewart, and H. J. Norton
New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis
J. Clin. Oncol., May 15, 2004; 22(10): 1778 - 1784.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. J. Feezor, E. M. Copeland III, and S. N. Hochwald
Significance of Micrometastases in Colorectal Cancer
Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953.
[Full Text] [PDF]


Home page
JCOHome page
S. Noura, H. Yamamoto, T. Ohnishi, N. Masuda, T. Matsumoto, O. Takayama, H. Fukunaga, Y. Miyake, M. Ikenaga, M. Ikeda, et al.
Comparative Detection of Lymph Node Micrometastases of Stage II Colorectal Cancer by Reverse Transcriptase Polymerase Chain Reaction and Immunohistochemistry
J. Clin. Oncol., October 15, 2002; 20(20): 4232 - 4241.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Noura, H. Yamamoto, Y. Miyake, B. no Kim, O. Takayama, I. Seshimo, M. Ikenaga, M. Ikeda, M. Sekimoto, N. Matsuura, et al.
Immunohistochemical Assessment of Localization and Frequency of Micrometastases in Lymph Nodes of Colorectal Cancer
Clin. Cancer Res., March 1, 2002; 8(3): 759 - 767.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.